These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31263154)

  • 1. Expression of neuropeptide Y is increased in an activated human HSC cell line.
    Dai W; Liu Y; Zhang Y; Sun Y; Sun C; Zhang Y; Lv X
    Sci Rep; 2019 Jul; 9(1):9500. PubMed ID: 31263154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells.
    Sigala B; McKee C; Soeda J; Pazienza V; Morgan M; Lin CI; Selden C; Vander Borght S; Mazzoccoli G; Roskams T; Vinciguerra M; Oben JA
    PLoS One; 2013; 8(9):e72928. PubMed ID: 24019886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y1 receptor inhibits cell growth through inactivating mitogen-activated protein kinase signal pathway in human hepatocellular carcinoma.
    Lv X; Zhao F; Huo X; Tang W; Hu B; Gong X; Yang J; Shen Q; Qin W
    Med Oncol; 2016 Jul; 33(7):70. PubMed ID: 27262566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome in mice overexpressing neuropeptide Y in noradrenergic neurons.
    Ailanen L; Ruohonen ST; Vähätalo LH; Tuomainen K; Eerola K; Salomäki-Myftari H; Röyttä M; Laiho A; Ahotupa M; Gylling H; Savontaus E
    J Endocrinol; 2017 Jul; 234(1):57-72. PubMed ID: 28468933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rev-erb agonist and TGF-β similarly affect autophagy but differentially regulate hepatic stellate cell fibrogenic phenotype.
    Thomes PG; Brandon-Warner E; Li T; Donohue TM; Schrum LW
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):137-147. PubMed ID: 27840152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y promotes beta-cell replication via extracellular signal-regulated kinase activation.
    Cho YR; Kim CW
    Biochem Biophys Res Commun; 2004 Feb; 314(3):773-80. PubMed ID: 14741702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y promotes hepatic apolipoprotein A1 synthesis and secretion through neuropeptide Y Y5 receptor.
    Liu B; Chen F
    Peptides; 2022 Aug; 154():170824. PubMed ID: 35660638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the neuropeptide Y (NPY)-receptor antagonist BIBP3226 on vascular NPY-receptors with different ligand requirements.
    Grundemar L; Ekelund M
    Pharmacol Toxicol; 1996 Nov; 79(5):266-9. PubMed ID: 8936561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of BIBP3226 on inositol phosphate accumulation and cytosolic calcium level in control and NPY Y1 receptor expressing CHO-K1 cells.
    Vanderheyden PM; Van Liefde I; DeBacker JP; Ebinger G; Vauquelin G
    Regul Pept; 1998 Sep; 75-76():191-9. PubMed ID: 9802409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
    Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
    Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of BIBP3226 and BIBP3435 on cytosolic calcium in neuropeptide Y Y1 receptor-transfected Chinese hamster ovary cells and wild type CHO-K1 cells.
    Van Liefde ; Vanderheyden PM; De Backer JP; Ebinger G; Vauquelin G
    J Recept Signal Transduct Res; 2001 Feb; 21(1):11-23. PubMed ID: 11693170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes.
    Yang CH; Ann-Onda D; Lin X; Fynch S; Nadarajah S; Pappas EG; Liu X; Scott JW; Oakhill JS; Galic S; Shi Y; Moreno-Asso A; Smith C; Loudovaris T; Levinger I; Eizirik DL; Laybutt DR; Herzog H; Thomas HE; Loh K
    Mol Metab; 2022 Jan; 55():101413. PubMed ID: 34890851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y functions as a neuroproliferative factor.
    Hansel DE; Eipper BA; Ronnett GV
    Nature; 2001 Apr; 410(6831):940-4. PubMed ID: 11309620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.
    Lu C; Everhart L; Tilan J; Kuo L; Sun CC; Munivenkatappa RB; Jönsson-Rylander AC; Sun J; Kuan-Celarier A; Li L; Abe K; Zukowska Z; Toretsky JA; Kitlinska J
    Oncogene; 2010 Oct; 29(41):5630-42. PubMed ID: 20676138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine-induced changes in the mice hippocampal neuropeptide Y system: implications for memory impairment.
    Gonçalves J; Baptista S; Olesen MV; Fontes-Ribeiro C; Malva JO; Woldbye DP; Silva AP
    J Neurochem; 2012 Dec; 123(6):1041-53. PubMed ID: 23061411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y-Y1 receptor agonist worsens while antagonist improves survival of cultured Y1-expressing neuronal cells following oxygen and glucose deprivation.
    Chen SH; Cheung RT
    J Biomed Sci; 2004; 11(6):781-8. PubMed ID: 15591775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S; Li DL; Simmons RM
    J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y release in the rat spinal cord measured with Y1 receptor internalization is increased after nerve injury.
    Marvizon JC; Chen W; Fu W; Taylor BK
    Neuropharmacology; 2019 Nov; 158():107732. PubMed ID: 31377198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y Y1-receptor stimulation is required for physiological amplification of preovulatory luteinizing hormone surges.
    Leupen SM; Besecke LM; Levine JE
    Endocrinology; 1997 Jul; 138(7):2735-9. PubMed ID: 9202211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.